In addition to its effects on the polarization of inflammatory reactive astrocyte states, we also found that IL-32 was induced by IFN-β (an old disease-modifying treatment for multiple sclerosis), and that IL32 transcript levels were upregulated in astrocytes in various multiple sclerosis lesions. This evidence concerns the gene IFNB1 and multiple sclerosis.